FULMEDIUM SIGNALFINANCIAL10-K

H.B. Fuller increased share buybacks substantially while experiencing weaker operating cash generation and depleting cash reserves.

The company appears to be prioritizing shareholder returns despite softer operational cash flow performance, suggesting management confidence in the business fundamentals. The meaningful reduction in cash reserves combined with elevated capital returns indicates a more aggressive capital allocation strategy that warrants monitoring for sustainability.

Comparing 2026-01-22 vs 2025-01-23View on EDGAR →
FINANCIAL ANALYSIS

Fuller delivered solid earnings growth with net income rising 16.7% to $152.0M while managing costs effectively through reduced R&D spending. However, operational performance showed mixed signals as operating cash flow declined 12.9% to $263.5M, yet the company substantially increased share buybacks and reduced its cash position by 37% to $107.2M. This pattern suggests management is deploying excess cash for shareholder returns while navigating some operational headwinds in cash generation.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+53.5%
$39.6M→$60.7M

Share repurchases increased 53.5% — management returning capital, signals confidence in intrinsic value.

Cash & Equivalents
Balance Sheet
-36.7%
$169.4M→$107.2M

Cash declined 36.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Net Income
P&L
+16.7%
$130.3M→$152.0M

Net income grew 16.7% — bottom-line growth signals improving overall business health.

R&D Expense
P&L
-13.5%
$24.6M→$21.2M

R&D spending cut 13.5% — could signal cost discipline or concerning reduction in innovation investment.

Operating Cash Flow
Cash Flow
-12.9%
$302.4M→$263.5M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2026-01-22
PRIOR — 2025-01-23
ADDED
ful20251130_10k.htm 0000039368 FULLER H B CO false --11-29 FY 2025 We periodically assess and test our policies, standards, processes and practices that are designed to address cybersecurity threats and incidents, including those from third-party service providers who have access to our systems, data or are critical to our continued business operations.
Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to H.B.
Other includes losses associated with ongoing litigation and product claims related to a divested business and costs associated with the exit of a product line for the year ended November 29, 2025.
Term Loan B, due on February 15, 2030, $994,000 variable rate at the SOFR plus 1.75 percent with a SOFR floor of 0.50 percent (5.67 percent at November 29, 2025).
Segment expenses and other items for all segments primarily include raw material costs, compensation and benefits, delivery expense, rent and lease expense, professional services, travel and entertainment, repairs and maintenance and other manufacturing overhead.
+7 more — sign up free →
REMOVED
Corporate assets include primarily corporate property, plant and equipment, deferred tax assets, certain investments and other assets.
Public Notes, due February 15, 2027, $300,000 4.00 percent fixed.
Term Loan A, due on February 15, 2028, $500,000 variable rate at the Secured Overnight Financing Rate ("SOFR") plus an adjustment of 0.10 percent and an interest rate spread of 1.50 percent based on a leverage grid (6.95 percent at December 2, 2023).
Term Loan B, due on February 15, 2028, $800,000 variable rate at the SOFR plus 2.25 percent with a SOFR floor of 0.50 percent (7.60 percent at December 2, 2023).
Consistent with our internal management reporting, Corporate Unallocated amounts in the tables above include charges that are not allocated to the Company s reportable segments.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →